Skip to main content Skip to search Skip to main navigation

PDA: New Publications and Formation of the D/A/CH Chapter

During the press conference of the PDA/FDA Joint Regulatory Conference 2024, PDA (Parenteral Drug Association) announced interesting new publications and the formation of the new D/A/CH Chapter to support local members.

New publications include:

  • Updated Technical Report 68 “Risk-Based Approach for Prevention and Management of Drug Shortages“
    Based on the impact this issue has to the pharmaceutical companies and the patients they supply, PDA provides this updated report free of charge globally.
  • In October the book “Global Sterile Manufacturing – Regulatory Guidance Comparison & Assessment Tools“ will be published.
    The book compares guidances from the FDA, EU, WHO, PIC/S, Canada, China and Japan. It simplyfies the challenging task of looking across regulatory guidances to ensure global compliance. It comes with explanations and Excel® files to work with.

PDA formed the new D/A/CH Chapter. The chapter region consists of Germany, Austria and German-speaking Switzerland. The chapter is led by Richard Denk of SKAN AG, Switzerland.


Source:

PDA Press Conference, 9 September 2024, Washington, DC

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

FDA: New Draft Guidance on Impurity Specifications for Antibiotics

FDA: New Draft Guidance on Impurity Specifications for Antibiotics

The US FDA has issued a new draft guidance (April 2026) on Impurity Specifications for Antibiotics.
Read more
EDQM: Guidance on Traceability of Medicines in Hospitals

EDQM: Guidance on Traceability of Medicines in Hospitals

The EDQM has published new guidance on the traceability of medicines in hospital settings. The aim is to improve traceability up to the point of administration and strengthen patient safety.
Read more
Which Measures are Crucial for Implementation and Monitoring of Data Integrity?

Which Measures are Crucial for Implementation and Monitoring of Data Integrity?

Here's the answer:
Read more
Contamination Control Strategy (CCS) – Not Just an Extended Site Master File

Contamination Control Strategy (CCS) – Not Just an Extended Site Master File

At the GMP-PharmaCongress in Wiesbaden, GMP inspector Frank Sielaff (Regional Authority in Darmstadt, Germany) shared practical insights from recent inspections, high-lighting deficiencies in CCS implementation.

Read more
EMA/HMA: Call for Regulatory Updates for Radiopharmaceuticals

EMA/HMA: Call for Regulatory Updates for Radiopharmaceuticals

In their „Horizon Scanning Report“, EMA and HMA have recommended updates to the regulatory framework to keep pace with developments in radiopharmaceuticals. Due to their unique characteristics these products require specific regulatory and scientific approaches.
Read more
How can the Specific Requirements for Sterile Products be Taken into Account in the Quality Management System?

How can the Specific Requirements for Sterile Products be Taken into Account in the Quality Management System?

Here's the answer:
Read more
Previous
Next